182 related articles for article (PubMed ID: 34079245)
1. Eicosanoids and Eosinophilic Inflammation of Airways in Stable COPD.
Celejewska-Wójcik N; Kania A; Górka K; Nastałek P; Wójcik K; Gielicz A; Mastalerz L; Sanak M; Sładek K
Int J Chron Obstruct Pulmon Dis; 2021; 16():1415-1424. PubMed ID: 34079245
[TBL] [Abstract][Full Text] [Related]
2. Relationship between Blood and Induced Sputum Eosinophils, Bronchial Hyperresponsiveness and Reversibility of Airway Obstruction in Mild-to-Moderate Chronic Obstructive Pulmonary Disease.
Proboszcz M; Mycroft K; Paplinska-Goryca M; Górska K; Nejman-Gryz P; Jankowski P; Zak N; Krenke R
COPD; 2019 Dec; 16(5-6):354-361. PubMed ID: 31631716
[TBL] [Abstract][Full Text] [Related]
3. Molecular markers of type 2 airway inflammation are similar between eosinophilic severe asthma and eosinophilic chronic obstructive pulmonary disease.
Fricker M; McDonald VM; Winter NA; Baines KJ; Wark PAB; Simpson JL; Gibson PG
Allergy; 2021 Jul; 76(7):2079-2089. PubMed ID: 33470427
[TBL] [Abstract][Full Text] [Related]
4. [Eosinophilic chronic obstructive pulmonary disease: A review].
Anaev EK
Ter Arkh; 2023 Oct; 95(8):696-700. PubMed ID: 38158908
[TBL] [Abstract][Full Text] [Related]
5. The association between airway eosinophilic inflammation and IL-33 in stable non-atopic COPD.
Tworek D; Majewski S; Szewczyk K; Kiszałkiewicz J; Kurmanowska Z; Górski P; Brzeziańska-Lasota E; Kuna P; Antczak A
Respir Res; 2018 Jun; 19(1):108. PubMed ID: 29859068
[TBL] [Abstract][Full Text] [Related]
6. Blood cell for the differentiation of airway inflammatory phenotypes in COPD exacerbations.
Gao J; Chen B; Wu S; Wu F
BMC Pulm Med; 2020 Feb; 20(1):50. PubMed ID: 32093672
[TBL] [Abstract][Full Text] [Related]
7. Application of Inflammatory Markers in Induced Sputum in Stable Chronic Obstructive Pulmonary Disease Patients with Positive Bronchodilation Tests.
Guo XX; Deng NS; Chen QH; Yu HY; Ding XH; Hu SP; Nie HX
Curr Med Sci; 2019 Aug; 39(4):560-567. PubMed ID: 31346991
[TBL] [Abstract][Full Text] [Related]
8. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
Mastalerz L; Celejewska-Wójcik N; Wójcik K; Gielicz A; Januszek R; Cholewa A; Stręk P; Sanak M
Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
[TBL] [Abstract][Full Text] [Related]
9. Post-bronchodilator Reversibility of FEV
Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW
Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
[TBL] [Abstract][Full Text] [Related]
10. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
[TBL] [Abstract][Full Text] [Related]
11. Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study.
Brightling CE; Bleecker ER; Panettieri RA; Bafadhel M; She D; Ward CK; Xu X; Birrell C; van der Merwe R
Lancet Respir Med; 2014 Nov; 2(11):891-901. PubMed ID: 25208464
[TBL] [Abstract][Full Text] [Related]
12. Eosinophils in COPD-Current Concepts and Clinical Implications.
Mycroft K; Krenke R; Górska K
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2565-2574. PubMed ID: 32251737
[TBL] [Abstract][Full Text] [Related]
13. CC16 as an Inflammatory Biomarker in Induced Sputum Reflects Chronic Obstructive Pulmonary Disease (COPD) Severity.
Chen M; Xu K; He Y; Jin J; Mao R; Gao L; Zhang Y; Wang G; Gao P; Xie M; Liu C; Chen Z
Int J Chron Obstruct Pulmon Dis; 2023; 18():705-717. PubMed ID: 37139166
[TBL] [Abstract][Full Text] [Related]
14. Association between Galectin-13 Expression and Eosinophilic Airway Inflammation in Chronic Obstructive Pulmonary Disease.
Yi L; Feng Y; Chen D; Jin Y; Zhang S
COPD; 2023 Dec; 20(1):101-108. PubMed ID: 36656660
[TBL] [Abstract][Full Text] [Related]
15. Sputum IL-25, IL-33 and TSLP, IL-23 and IL-36 in airway obstructive diseases. Reduced levels of IL-36 in eosinophilic phenotype.
Moermans C; Damas K; Guiot J; Njock MS; Corhay JL; Henket M; Schleich F; Louis R
Cytokine; 2021 Apr; 140():155421. PubMed ID: 33486314
[TBL] [Abstract][Full Text] [Related]
16. Eosinophilic airway inflammation in COPD.
Saha S; Brightling CE
Int J Chron Obstruct Pulmon Dis; 2006; 1(1):39-47. PubMed ID: 18046901
[TBL] [Abstract][Full Text] [Related]
17. Airway inflammation and mannitol challenge test in COPD.
de Nijs SB; Fens N; Lutter R; Dijkers E; Krouwels FH; Smids-Dierdorp BS; van Steenwijk RP; Sterk PJ
Respir Res; 2011 Jan; 12(1):11. PubMed ID: 21241520
[TBL] [Abstract][Full Text] [Related]
18. Sputum Gene Expression Reveals Dysregulation of Mast Cells and Basophils in Eosinophilic COPD.
Winter NA; Gibson PG; McDonald VM; Fricker M
Int J Chron Obstruct Pulmon Dis; 2021; 16():2165-2179. PubMed ID: 34321876
[TBL] [Abstract][Full Text] [Related]
19. A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
Greulich T; Hohlfeld JM; Neuser P; Lueer K; Klemmer A; Schade-Brittinger C; Harnisch S; Garn H; Renz H; Homburg U; Renz J; Kirsten A; Pedersen F; Müller M; Vogelmeier CF; Watz H
Respir Res; 2018 Apr; 19(1):55. PubMed ID: 29615049
[TBL] [Abstract][Full Text] [Related]
20. Blood and Sputum Eosinophils of COPD Patients Are Differently Polarized than in Asthma.
Mycroft K; Paplińska-Goryca M; Proboszcz M; Nejman-Gryz P; Krenke R; Górska K
Cells; 2023 Jun; 12(12):. PubMed ID: 37371101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
